Clinical trial
Effects of Gabapentin in the Treatment of Neuropathic Pain on Driving…
NCT00189072 · UMC Utrecht, Other · Terminated
Key facts
| NCT number | NCT00189072 |
|---|---|
| Title | Effects of Gabapentin in the Treatment of Neuropathic Pain on Driving Performance and Cognition |
| Official title | Effects of Pain and the Treatment of Pain With Gabapentin (900-3600 Mg) on Driving Ability, Attentional Capacity and Psychomotor Performance in Chronic Neuropathic Pain Patients |
| Lead sponsor | UMC Utrecht, Other |
| Collaborators | Utrecht University |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Neuropathic Pain |
| Intervention type | Drug |
| Interventions | gabapentin |
| Enrollment | 24 |
| Start date | Apr 1, 2003 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 16, 2005 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: